ArticleJournal of human genetics2026
Gardos channelopathies: novel insights into KCNN4 mutations and their clinical impact.
Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NovelHuman mutation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Gardos channelopathies are rare hereditary hemolytic anaemias caused by mutations in the KCNN4 gene, which encodes the calcium-activated potassium channel (KCa3.1) in red blood cells. In this study, we report three unrelated Indian patients with unexplained chronic hemolytic anaemia. Whole exome sequencing revealed distinct KCNN4 mutations: a homozygous c.5G > A mutation (p.Gly2Asp) in Case I, a compound heterozygous condition with the Hb Nottingham mutation (HBB: c.296T > G) and a splice-site mutation in KCNN4 (c.931-1G > C) in Case II, and homozygous c.541A > T mutation (p.Ser181Cys) in Case III. All three patients presented with chronic anaemia, indirect hyperbilirubinemia, reticulocytosis, and recurrent blood transfusions. Red cell enzyme studies (G6PD, PK, GPI) showed normal activities, and flow cytometry-based EMA binding was normal. Haemoglobin electrophoresis by HPLC was normal, except in Case II, and tested positive for unstable haemoglobin using a heat instability test. Flow cytometry revealed significantly elevated intracellular calcium levels and reactive oxygen species (ROS) in all cases, indicating oxidative stress under osmotic stress. In Case III, a Percoll density gradient assay demonstrated dehydrated erythrocytes, supporting the diagnosis. This study expands the mutation spectrum of Genetic diagnosis using NGS, which is essential for appropriate clinical management and genetic counselling in unexplained cases of hemolytic anaemia. Elevated intracellular calcium levels play a key role in hemolysis, suggesting that calcium-modulating therapies could aldehyleviate symptoms.
Indexed as
Identifiers
41168459What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.